4.7 Review

Unraveling structural mechanisms of allosteric drug action

Journal

TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 35, Issue 5, Pages 256-264

Publisher

ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tips.2014.03.006

Keywords

allosteric drug discovery; protocol; agonist; antagonist; driver atom; anchor atom; allostery

Funding

  1. National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]
  2. Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research

Ask authors/readers for more resources

Orthosteric drugs block the active site to obstruct function; allosteric drugs modify the population of the active state, to modulate function. Available data lead us to propose that allosteric drugs can constitute anchors and drivers. The anchor docks into an allosteric pocket. The conformation with which it interacts is unchanged during the transition between the inactive and active states. The anchor provides the foundation that allows the driver to exert a 'pull' and/or 'push' action that shifts the receptor population from the inactive to the active state. The presence or absence of driver atom in an allosteric drug can exert opposite agonism. We map a strategy for driver identification and expect the allosteric trigger concept to transform agonist/antagonist drug discovery.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available